MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0066951
Eumark Pharmaceuticals Pvt Ltd - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.13 Cr
▲ 16% YoY
Net profit · FY 2025
₹73.03 Lakh
Net margin 4.8%
EBITDA · FY 2025
₹2.05 Cr
EBITDA margin 13.5%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹2.14 Cr
Secured borrowings
Company age
42 yrs
Est. 1984
Employees · EPFO
24
Provident fund records
About Eumark Pharmaceuticals Pvt Ltd
Data last updated:
Eumark Pharmaceuticals Pvt Ltd is a private limited company based in Ambernath, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1984PTC032534. Its GSTIN is 27AABCE3162H1ZU (Maharashtra).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Bhooshan Madhukar Pai and Karuna Bhooshan Pai.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 22 MIDC Additional Ambernath East, Maharashtra, India – 421506.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.13 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹73.03 Lakh (net margin 4.8%) and EBITDA of ₹2.05 Cr (EBITDA margin 13.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.14 Cr on record.
Eumark Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0066951). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eumarkpharma.com.
Company details
CIN U24230MH1984PTC032534
Registration Number 032534
Incorporation Date 30 March 1984
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0066951
Recognitions & Rankings of Eumark Pharmaceuticals
Contact details
Eumark Pharmaceuticals Pvt Ltd's registered office is in Ambernath, Maharashtra. Its website is eumarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 22 MIDC Additional Ambernath East, Maharashtra, India – 421506
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Eumark Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Eumark Pharmaceuticals are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Eumark Pharmaceuticals Pvt Ltd
FY 2025 filings availableEumark Pharmaceuticals Pvt Ltd reported revenue of ₹15.13 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹15.13 Cr ▲ 16%
Net profit · FY 2025
₹73.03 Lakh margin 4.8%
EBITDA · FY 2025
₹2.05 Cr margin 13.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 1%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▼ 2%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 16% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.5% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Eumark Pharmaceuticals Pvt Ltd
Eumark Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhooshan Madhukar Pai | Director | 30 Mar 1984 | 42 Years 6 Months | Current |
| Karuna Bhooshan Pai Also directs: Avanom Healthcare LLP | Director | 31 Jul 2003 | 23 Years 2 Months | Current |
Peer comparison
Eumark Pharmaceuticals Pvt Ltd is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| National Capsules Private Limited | ₹15.19 Cr (FY 2024) | -39.0% | Vidisha, Madhya Pradesh, India | |||
| Shiv Shakti Pharma Care Private Limited | ₹15.19 Cr (FY 2025) | -49.0% | Vapi, Gujarat, India | |||
| Nicosia Biolabs International Private Limited | ₹15.16 Cr (FY 2024) | 66.0% | Ludhiana, Punjab, India | |||
| Eumark Pharmaceuticals Pvt Ltdthis company | ₹15.13 Cr (FY 2025) | ₹73.03 Lakh | 4.8% | 16.0% | 24 | Ambernath, Maharashtra, India |
| Arco Pharma Private Limited | ₹15.11 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Amba Pigments & Chemicals Private Limited | ₹15.08 Cr (FY 2025) | 13.0% | Delhi, India | |||
| Coax Bioremedies Private Limited | ₹15.08 Cr (FY 2025) | 33.0% | Haryana, India |
To see the full peer comparison of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Eumark Pharmaceuticals Pvt Ltd is audited by SVARA GHARAT & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SVARA GHARAT & ASSOCIATES | FY 2023 | 157861W |
Shareholding
The shareholding of Eumark Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹2.14 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2014 | 10540897 | The Saraswat Co-Operative Bank Ltd. | ₹60 Lakh | Open | |
| 17 Sep 2014 | 10520766 | Electronica Finance Limited | ₹18.62 Lakh | Open | |
| 17 Sep 2014 | 10520769 | Electronica Finance Limited | ₹12.21 Lakh | Open | |
| 24 Dec 2013 | 10469331 | The Saraswat Co-Operative Bank Ltd. | ₹40 Lakh | Open | |
| 27 Apr 2013 | 10424871 | The Saraswat Co-Operative Bank Ltd. | ₹13.5 Lakh | Open |
To see the full charge records of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 8 View all charges
Legal cases
No court or tribunal cases involving Eumark Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Eumark Pharmaceuticals Pvt Ltd has 13 MSME Form 1 returns on record between 2018 and 2023, listing 333 overdue payments to 39 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 39)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Kalapi Printing Press | |||
| Space Age Plastic Industries | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Eumark Pharmaceuticals Pvt Ltd has a workforce of 24 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
GST
Eumark Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE3162H1ZU | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eumark Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Eumark Pharmaceuticals Pvt Ltd has 2 board changes on record since 1984: 2 appointments. The latest: Karuna Bhooshan Pai was appointed as Director on 31 Jul 2003.
AGM
Eumark Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Eumark Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with The Saraswat Co-Operative Bank Ltd. amounted to Rs. 60.00 Lakh with Charge ID 10540897 was registered on 10 Dec 2014.
Charges
A charge with Electronica Finance Limited amounted to Rs. 18.62 Lakh with Charge ID 10520766 was registered on 17 Sep 2014.
Charges
A charge with Electronica Finance Limited amounted to Rs. 12.21 Lakh with Charge ID 10520769 was registered on 17 Sep 2014.
Charges
A charge with The Saraswat Co-Operative Bank Ltd. amounted to Rs. 40.00 Lakh with Charge ID 10469331 was registered on 24 Dec 2013.
Charges
A charge with The Saraswat Co-Operative Bank Ltd. amounted to Rs. 13.50 Lakh with Charge ID 10424871 was registered on 27 Apr 2013.
Charges
A charge with The Saraswat Co-Operative Bank Limited of Rs. 30.00 Lakh registered on 23 Apr 2008 with Charge ID 10110380 was modified on 05 Jan 2012.
Charges
A charge with The Saraswat Co-Operative Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 10214343 was registered on 17 Apr 2010.
Charges
A charge with The Saraswat Co-Operative Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 10110380 was registered on 23 Apr 2008.
Charges
A charge with The United Western Bank Ltd. amounted to Rs. 15.00 Lakh with Charge ID 10012920 was registered on 08 Aug 2006.
Appointed
Karuna Bhooshan Pai was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Eumark Pharmaceuticals is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 1984 (42+ years old) and is registered under CIN U24230MH1984PTC032534.
Eumark Pharmaceuticals has 2 current directors:
- Bhooshan Madhukar Pai - Director
- Karuna Bhooshan Pai - Director
The latest financial statements of Eumark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Eumark Pharmaceuticals is 27AABCE3162H1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Eumark Pharmaceuticals is U24230MH1984PTC032534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eumark Pharmaceuticals was incorporated on 30 March 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Eumark Pharmaceuticals by revenue are National Capsules Private Limited, Shiv Shakti Pharma Care Private Limited, Nicosia Biolabs International Private Limited, Arco Pharma Private Limited, Amba Pigments & Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Karuna Bhooshan Pai was appointed as Director on 31 Jul 2003. Bhooshan Madhukar Pai was appointed as Director on 30 Mar 1984.
Yes, Eumark Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0066951).
Eumark Pharmaceuticals has 13 MSME Form 1 returns on record between 2018 and 2023, listing 333 overdue payments to 39 micro and small suppliers. The latest return was filed on 08 Nov 2023.
Eumark Pharmaceuticals can be reached through the website eumarkpharma.com. Its registered office is in Ambernath, Maharashtra, India.
The registered office of Eumark Pharmaceuticals is at A – 22 MIDC Additional Ambernath East, Maharashtra, India – 421506.